Related Experiment Video
Updated: Mar 6, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions
Koki Nakanishi1, Zhezhen Jin2, Shunichi Homma1
1Department of Medicine, Columbia University, New York, NY.
Insights
Left ventricular hypertrophy, both concentric and eccentric, is linked to silent cerebrovascular disease. These heart conditions increase stroke risk, especially in certain demographics.
Area of Science:
- Cardiology
- Neurology
- Radiology
Background:
- Abnormal left ventricular (LV) geometric patterns are known prognostic indicators for morbidity and mortality.
- The association between LV geometric patterns and silent cerebrovascular disease (SCVD) remains underexplored.
Purpose of the Study:
- To investigate the relationship between different left ventricular geometric patterns and the presence of subclinical cerebrovascular disease.
- To determine if specific LV geometric patterns are associated with silent brain infarcts (SBIs) and white matter hyperintensity volume (WMHV).
Main Methods:
- A cohort of 665 participants from the CABL study underwent echocardiography and brain MRI.
- Participants were categorized into four LV geometric patterns: normal, concentric remodeling, eccentric hypertrophy, and concentric hypertrophy.
- SCVD was assessed by the presence of SBIs and the volume of WMHV.
Main Results:
- Concentric hypertrophy showed the highest risk for both SBIs (aOR 3.39) and WMHV (aOR 3.35).
- Eccentric hypertrophy also demonstrated significant associations with SBIs (aOR 2.52) and WMHV (aOR 1.96).
- Concentric remodeling was not associated with SCVD. Associations varied across sex, age, and race-ethnic subgroups.
Conclusions:
- Left ventricular hypertrophy, encompassing both eccentric and concentric patterns, is significantly associated with subclinical cerebrovascular disease in a general, stroke-free population.
- LV geometric patterns may confer differential risks for SCVD depending on demographic factors such as sex, age, race-ethnicity, and body size.
Background:
Although abnormal left ventricular geometric patterns have prognostic value for morbidity and mortality, their possible association with silent cerebrovascular disease has not been extensively evaluated.
Methods:
We examined 665 participants in the CABL study who underwent transthoracic echocardiography and brain magnetic resonance imaging. Participants were divided into 4 geometric patterns: normal geometry (n=397), concentric remodeling (n=89), eccentric hypertrophy (n=126), and concentric hypertrophy (n=53). Subclinical cerebrovascular disease was defined as silent brain infarcts (SBIs) and white matter hyperintensity volume (WMHV; expressed as log-transformed percentage of the total cranial volume).
Results:
Silent brain infarcts were observed in 94 participants (14%). Mean log-WMHV was -0.97±0.93. Concentric hypertrophy carried the greatest risk for both SBI (adjusted odds ratio [OR] 3.39, P<.001) and upper quartile of log-WMHV (adjusted OR 3.35, P<.001), followed by eccentric hypertrophy (adjusted ORs 2.52 [P=.001 for SBI] and 1.96 [P=.004] for log-WMHV). Concentric remodeling was not associated with subclinical brain disease. In subgroup analyses, concentric and eccentric hypertrophies were significantly associated with SBI and WMHV in both genders and nonobese participants, but differed for SBI by age (all ages for eccentric hypertrophy, only patients ≥70years for concentric hypertrophy) and by race-ethnicity (Hispanics for eccentric hypertrophy, blacks for concentric hypertrophy; no association in whites).
Conclusions:
Left ventricular hypertrophy, with both eccentric and concentric patterns, was significantly associated with subclinical cerebrovascular disease in a multiethnic stroke-free general population. Left ventricular geometric patterns may carry different risks for silent cerebrovascular disease in different sex, age, race-ethnic, and body size subgroups.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

